Cleared Traditional

K123798 - LIQUIDCHEK DIABETES CONTROL

Also marketed or referenced as:
LEVEL 1, LEVEL 2, LEVEL 3, TRILEVEL MINIPAK

K123798 is an FDA 510(k) clearance for LIQUIDCHEK DIABETES CONTROL, manufactured by Bio-Rad Laboratories. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
30d
Days
Class 1
Risk

K123798 is an FDA 510(k) clearance for the LIQUIDCHEK DIABETES CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bio-Rad Laboratories (Irvine, US). The FDA issued a Cleared decision on January 9, 2013 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad Laboratories devices

FDA 510(k) Submission Details - K123798

510(k) Number K123798 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 2012
Decision Date January 09, 2013
Days to Decision 30 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 434
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K123798.
GLUCOSE METER-CHECK SOLUTION FOR ROCHE ACCU-CHEK
K123851 · Bionostics, Inc. · Feb 2013
GLUCOSE METER-CHECK SOLUTION FOR BAYER
K123966 · Bionostics, Inc. · Jan 2013
FDI GLUCOSE CONTROL SOLUTION FOR USE WITH ACCU-CHEK AVIVA
K123612 · Fujirebio Diagnostics,Inc. · Jan 2013
ELECSYS CA 15-3 II CALCHECK 5
K122242 · Roche Diagnostics · Dec 2012
ELECSYS HSV-2 IGG IMMUNOASSAY
K121895 · Roche Diagnostics · Aug 2012
IDS-ISYS IGF-I CALIBRATION VERIFIERS
K122141 · Immunodiagnostic Systems , Ltd. · Aug 2012